The New York Times, December 16, 2020. A CDC division is working with an industry standards group to create standards for mask safety and effectiveness.
Read More »Tag: Covid-19
FDA Panel Reviewing Pfizer Vaccine Leaves Out Some Experts Who Raised Concerns
POGO, December 9, 2020. FDA’s coronavirus vaccine panel did not include experts who raised concerns about Pfizer’s data at a previous meeting.
Read More »Testimony of Dr. Diana Zuckerman of NCHR before the FDA Advisory Committee on Pfizer COVID Vaccine
December 10, 2020: We need longer-term data on the Pfizer COVID-19 vaccine to fully understand if benefits outweigh the risks for frail patients and all races/ethnicities, and for everyone else as well. It is essential that FDA ensure the continuation of the randomized controlled trial.
Read More »Public Comments Regarding ACIP Meeting on December 1, 2020
December 1, 2020: We are concerned about the lack of data on the vaccines in patients living in long-term care facilities, or any patients over 65 years of age.
Read More »Four ways Trump has meddled in pandemic science — and why it matters
Nature, November 3, 2020. Donald Trump’s response to the COVID-19 pandemic looms large in the election. One issue that resonates with the research community, including NCHR, is the extent to which the current president and his administration have meddled with science and scientific advice during the pandemic — often with disastrous results.
Read More »